These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 7024758)

  • 41. Failures of combined chloroquine and Fansidar prophylaxis in American travelers to East Africa.
    Miller KD; Lobel HO; Pappaioanou M; Patchen LC; Churchill FC
    J Infect Dis; 1986 Oct; 154(4):689-91. PubMed ID: 3528321
    [No Abstract]   [Full Text] [Related]  

  • 42. Indications for the use of Fansidar in malaria.
    Schwartz IK; Campbell CC
    N Engl J Med; 1982 Jul; 307(3):194. PubMed ID: 7088068
    [No Abstract]   [Full Text] [Related]  

  • 43. [Effectiveness of treatment with chloroquine, fansidar and dabequin of Plasmodium falciparum carriers, residing in a hyperendemic focus of malaria (the city of Bagamoyo, Northeastern Tanzania)].
    Kuznetsov RL; Kilama V; Peĭn D; Kampbell SS; Stori D
    Med Parazitol (Mosk); 1985; (4):15-9. PubMed ID: 3903459
    [No Abstract]   [Full Text] [Related]  

  • 44. Fansidar in malaria prophylaxis.
    Bradley DJ; Hall AP; Peters W; Warhurst D
    Br Med J (Clin Res Ed); 1985 Jul; 291(6488):136. PubMed ID: 3926082
    [No Abstract]   [Full Text] [Related]  

  • 45. [Unsuccessful effect of sulfadoxine-pyrimethamine in the treatment of falciparum malaria in Tanzania].
    Vestergaard Olsen V
    Ugeskr Laeger; 1983 Mar; 145(10):751. PubMed ID: 6344376
    [No Abstract]   [Full Text] [Related]  

  • 46. Parenteral Fansidar in falciparum malaria.
    Harinasuta T; Viravan C; Buranasin P
    Trans R Soc Trop Med Hyg; 1988; 82(5):694. PubMed ID: 3075356
    [No Abstract]   [Full Text] [Related]  

  • 47. Effects of Fansidar on chloroquine-resistant Plasmodium falciparum in Pakistan.
    Strickland GT; Khaliq AA; Sarwar M; Hassan H; Pervez M; Fox E
    Am J Trop Med Hyg; 1986 Jan; 35(1):61-5. PubMed ID: 3511752
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Falciparum malaria cured by quinine followed by sulfadoxine-pyrimethamine.
    Hall AP; Doberstyn EB; Mettaprakong V; Sonkom P
    Br Med J; 1975 Apr; 2(5961):15-7. PubMed ID: 1093610
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Fansimef in the treatment of malaria.
    Prociv P
    Aust N Z J Med; 1989 Aug; 19(4):411. PubMed ID: 2675819
    [No Abstract]   [Full Text] [Related]  

  • 50. Fansidar for malaria prophylaxis.
    Kissane D
    Aust Fam Physician; 1985 Aug; 14(8):738. PubMed ID: 3901990
    [No Abstract]   [Full Text] [Related]  

  • 51. Use of pyrimethamine-sulfadoxine (Fansidar) in prophylaxis against chloroquine-resistant Plasmodium falciparum and Pneumocystis carinii.
    Pearson RD; Hewlett EL
    Ann Intern Med; 1987 May; 106(5):714-8. PubMed ID: 3551713
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Treatment of falciparum malaria with sulfalene-pyrimethamine versus sulfadoxine-pyrimethamine.
    Chongsuphajaisiddhi T; Youngchaiyudha S; Rungpitarangsri V; Trishnananda M; Ruksakul T; Charnond L; Boonamrung S
    Southeast Asian J Trop Med Public Health; 1980 Dec; 11(4):524-7. PubMed ID: 7013094
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Fansimef [Fansidar plus mefloquine] is effective treatment for imported malaria in New Zealand.
    Ellis-Pegler RB; Beeching NJ; Eales M; Fraser AG; Wells AU
    Aust N Z J Med; 1988 Aug; 18(5):733-4. PubMed ID: 3072955
    [No Abstract]   [Full Text] [Related]  

  • 54. Comparison of the susceptibility of falciparum malaria to mefloquine-sulphadoxine-pyrimethamine and chloroquine in Nigeria.
    Fadeke Aderounmu A; Salako LA; Laoye AJ; Modupe Makinde J; Aina Adio R
    Afr J Med Med Sci; 1988 Dec; 17(4):195-200. PubMed ID: 2854365
    [TBL] [Abstract][Full Text] [Related]  

  • 55. In vivo and in vitro susceptibility of Plasmodium falciparum to sulphadoxine/pyrimethamine in Liberia, West Africa.
    Björkman A; Willcox M
    Trans R Soc Trop Med Hyg; 1986; 80(4):572-4. PubMed ID: 3544359
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Effects of chloroquine, amodiaquine and pyrimethamine-sulfadoxine on Plasmodium falciparum gametocytemia.
    Strickland GT; Fox E; Sarwar M; Khaliq AA; Macdonald M
    Am J Trop Med Hyg; 1986 Mar; 35(2):259-62. PubMed ID: 3513644
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The combined use of artemether, sulfadoxine and pyrimethamine in the treatment of uncomplicated falciparum malaria.
    U Thet Naing ; U Hla Win ; Daw Yin Yin Nwe ; U Pe Than Myint ; U Tin Shwe
    Trans R Soc Trop Med Hyg; 1988; 82(4):530-1. PubMed ID: 3076708
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Response of Plasmodium falciparum infections to pyrimethamine-sulfadoxine in Thailand.
    Rieckmann K; Suebsaeng L; Rooney W
    Am J Trop Med Hyg; 1987 Sep; 37(2):211-6. PubMed ID: 3310675
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Pyrimethamine/sulfadoxine for falciparum malaria.
    Watt G; Shanks GD
    Lancet; 1991 Sep; 338(8768):700-1. PubMed ID: 1679503
    [No Abstract]   [Full Text] [Related]  

  • 60. Fansidar for falciparum malaria.
    Kingston D
    Aust Fam Physician; 1979 May; 8(5):544. PubMed ID: 380540
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.